Vitruvian Partners LLP Long-Term Concentrated

CIK: 0001692590 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 10, 2025

Total Value ($000): $144,189 (100.0% shares, 0.0% debt)

Holdings (7)

HNGE HINGE HEALTH INC 42.5%

Value ($000) $61,350 Shares 1,250,000 Est. Cost $40.42 Unrealized +29.4%

MQ MARQETA 25.1%

Value ($000) $36,185 Shares 6,853,183 Est. Cost $29.82 Unrealized -80.1%

CARG CARGURUS INC 12.2%

Value ($000) $17,608 Shares 472,959 Est. Cost $29.39 Unrealized +16.3%

XMTR XOMETRY INC 8.9%

Value ($000) $12,836 Shares 235,660 Est. Cost $25.01 Unrealized +73.5%

MXCT MAXCYTE 5.5%

Value ($000) $7,969 Shares 5,043,356 Est. Cost $12.03 Unrealized -85.6%

GLBE GLOBAL-E 4.3%

Value ($000) $6,167 Shares 172,442 Est. Cost $46.29 Unrealized -26.3%

RXST RXSIGHT 1.4%

Value ($000) $2,074 Shares 230,743 Est. Cost $39.33 Unrealized -77.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
HNGE	HINGE HEALTH INC	1,250,000	$61,350	42.5%	$40.42	+29.4%	CL A	433313103
MQ	MARQETA	6,853,183	$36,185	25.1%	$29.82	-80.1%	CLASS A COM	57142B104
CARG	CARGURUS INC	472,959	$17,608	12.2%	$29.39	+16.3%	COM CL A	141788109
XMTR	XOMETRY INC	235,660	$12,836	8.9%	$25.01	+73.5%	CLASS A COM	98423F109
MXCT	MAXCYTE	5,043,356	$7,969	5.5%	$12.03	-85.6%	COM	57777K106
GLBE	GLOBAL-E	172,442	$6,167	4.3%	$46.29	-26.3%	SHS	M5216V106
RXST	RXSIGHT	230,743	$2,074	1.4%	$39.33	-77.7%	COM	78349D107